Brugada syndrome induced by BRAF and MEK inhibitors in a melanoma patient.
Centre Hospitalier Universitaire, Service de Dermatologie, CHU, 3 Bd Fleming, 25030, Besançon, France.|Université de Bourgogne-Franche Comté, Besançon, EA3181, France.
Charlée
C
Nardin
Centre Hospitalier Universitaire, Service de Dermatologie, CHU, 3 Bd Fleming, 25030, Besançon, France.
Morgane
M
Colas
Centre Hospitalier Universitaire, Service de Cardiologie, CHU, 3 Bd Fleming, 25030 Besançon, France.
Marc
M
Badoz
Centre Hospitalier Universitaire, Service de Dermatologie, CHU, 3 Bd Fleming, 25030, Besançon, France.
Blandine
B
Roche-Kubler
Centre Hospitalier Universitaire, Service de Cardiologie, CHU, 3 Bd Fleming, 25030 Besançon, France.
Nicolas
N
Meneveau
Centre Hospitalier Universitaire, Service de Dermatologie, CHU, 3 Bd Fleming, 25030, Besançon, France.|Université de Bourgogne-Franche Comté, Besançon, EA3181, France.
Eve
E
Puzenat
Centre Hospitalier Universitaire, Service de Dermatologie, CHU, 3 Bd Fleming, 25030, Besançon, France.|Université de Bourgogne-Franche Comté, Besançon, EA3181, France.
François
F
Aubin
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D053840:Brugada Syndrome / Q000139:chemically induced*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D010091:Oximes / Q000008:administration & dosage / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors; D011728:Pyridones / Q000008:administration & dosage / Q000009:adverse effects*; D011744:Pyrimidinones / Q000008:administration & dosage / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy*
D007093:Imidazoles; D010091:Oximes; D047428:Protein Kinase Inhibitors; D011728:Pyridones; D011744:Pyrimidinones; C560077:trametinib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; C561627:dabrafenib